112 related articles for article (PubMed ID: 38009602)
21. The potential value of lncRNA-BC050642 in osteosarcoma origination and outcomes.
Yang Y; Fei M; Zhou X; Li Y; Jin D
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1859-1866. PubMed ID: 31397185
[No Abstract] [Full Text] [Related]
22. Vitamin D Represses the Aggressive Potential of Osteosarcoma.
Tahbazlahafi B; Paknejad M; Khaghani S; Sadegh-Nejadi S; Khalili E
Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1312-1318. PubMed ID: 32955002
[TBL] [Abstract][Full Text] [Related]
23. Unraveling T cell exhaustion in the immune microenvironment of osteosarcoma via single-cell RNA transcriptome.
Cheng D; Zhang Z; Liu D; Mi Z; Tao W; Fu J; Fan H
Cancer Immunol Immunother; 2024 Jan; 73(2):35. PubMed ID: 38280005
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance and immune landscape of a novel ferroptosis-related prognosis signature in osteosarcoma.
Yang L; Liu J; Liu S
BMC Cancer; 2023 Mar; 23(1):229. PubMed ID: 36899330
[TBL] [Abstract][Full Text] [Related]
25. Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma.
Yang J; Zhang A; Luo H; Ma C
Sci Rep; 2022 Jan; 12(1):1279. PubMed ID: 35075228
[TBL] [Abstract][Full Text] [Related]
26. Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma.
Zhang Z; Zhu Z; Fu J; Liu X; Mi Z; Tao H; Fan H
Int Immunopharmacol; 2023 Feb; 115():109684. PubMed ID: 36630752
[TBL] [Abstract][Full Text] [Related]
27. Development of an immune-related prognostic index associated with osteosarcoma.
Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
[TBL] [Abstract][Full Text] [Related]
28. How microRNA and transcription factor co-regulatory networks affect osteosarcoma cell proliferation.
Poos K; Smida J; Nathrath M; Maugg D; Baumhoer D; Korsching E
PLoS Comput Biol; 2013; 9(8):e1003210. PubMed ID: 24009496
[TBL] [Abstract][Full Text] [Related]
29. Integrated analysis of single-cell and bulk RNA sequencing data reveals prognostic characteristics of lysosome-dependent cell death-related genes in osteosarcoma.
Wu Y; Yang J; Xu G; Chen X; Qu X
BMC Genomics; 2024 Apr; 25(1):379. PubMed ID: 38632516
[TBL] [Abstract][Full Text] [Related]
30. circUBAP2 regulates osteosarcoma progression via the miR‑204‑3p/HMGA2 axis.
Ma W; Xue N; Zhang J; Wang D; Yao X; Lin L; Xu Q
Int J Oncol; 2021 Mar; 58(3):298-311. PubMed ID: 33650644
[TBL] [Abstract][Full Text] [Related]
31. miR-541 serves as a prognostic biomarker of osteosarcoma and its regulatory effect on tumor cell proliferation, migration and invasion by targeting TGIF2.
Liu C; Yi X
Diagn Pathol; 2020 Jul; 15(1):96. PubMed ID: 32709240
[TBL] [Abstract][Full Text] [Related]
32. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
Liu R; Hu Y; Liu T; Wang Y
BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times.
Selvarajah GT; Kirpensteijn J; van Wolferen ME; Rao NA; Fieten H; Mol JA
Mol Cancer; 2009 Sep; 8():72. PubMed ID: 19735553
[TBL] [Abstract][Full Text] [Related]
34. LINC00324 accelerates the proliferation and migration of osteosarcoma through regulating WDR66.
Wu S; Gu Z; Wu Y; Wu W; Mao B; Zhao S
J Cell Physiol; 2020 Jan; 235(1):339-348. PubMed ID: 31225659
[TBL] [Abstract][Full Text] [Related]
35. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of copper-metabolism-related genes about prognosis and immune microenvironment in osteosarcoma.
Lin Z; He Y; Wu Z; Yuan Y; Li X; Luo W
Sci Rep; 2023 Sep; 13(1):15059. PubMed ID: 37700003
[TBL] [Abstract][Full Text] [Related]
37. An Exploration of Osteosarcoma Metastasis Diagnostic Markers Based on Tumor-Associated Neutrophils.
Tan S; Chao R
Discov Med; 2023 Jun; 35(176):300-311. PubMed ID: 37272097
[TBL] [Abstract][Full Text] [Related]
38. MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT/mTOR pathway.
Wang L; Yang Y; Wang XM; Wang CQ; Zhang YM; Li BL
J Recept Signal Transduct Res; 2020 Dec; 40(6):584-590. PubMed ID: 32456526
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma.
Li F; Cao L; Hang D; Wang F; Wang Q
Int J Clin Exp Pathol; 2015; 8(9):11414-20. PubMed ID: 26617868
[TBL] [Abstract][Full Text] [Related]
40. MCAM is associated with metastasis and poor prognosis in osteosarcoma by modulating tumor cell migration.
Du X; Zhang Q; Wang S; Chen X; Wang Y
J Clin Lab Anal; 2022 Feb; 36(2):e24214. PubMed ID: 34961985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
